35.09 USD
-1.03 (-2.85%)
35.77 USD
+0.68 (+1.94%)
We assign a fundamental rating of 4 out of 10 to ATRC. ATRC was compared to 188 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for ATRC as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, ATRC is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year ATRC has reported negative net income.
ATRC had a positive operating cash flow in the past year.
ATRC had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ATRC reported negative operating cash flow in multiple years.
1.2 Ratios
With a decent Return On Assets value of -4.60%, ATRC is doing good in the industry, outperforming 66.49% of the companies in the same industry.
ATRC has a better Return On Equity (-6.13%) than 69.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.6% | ||
| ROE | -6.13% | ||
| ROIC | N/A |
ROA(3y)-6.75%
ROA(5y)-3.76%
ROE(3y)-8.8%
ROE(5y)-5.54%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ATRC has a better Gross Margin (74.87%) than 86.17% of its industry peers.
In the last couple of years the Gross Margin of ATRC has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for ATRC so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 74.87% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y0.24%
2. Health
2.1 Basic Checks
ATRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ATRC has more shares outstanding
The number of shares outstanding for ATRC has been increased compared to 5 years ago.
The debt/assets ratio for ATRC is higher compared to a year ago.
2.2 Solvency
ATRC has an Altman-Z score of 6.77. This indicates that ATRC is financially healthy and has little risk of bankruptcy at the moment.
ATRC has a Altman-Z score of 6.77. This is amongst the best in the industry. ATRC outperforms 83.51% of its industry peers.
The Debt to FCF ratio of ATRC is 4.19, which is a neutral value as it means it would take ATRC, 4.19 years of fcf income to pay off all of its debts.
ATRC's Debt to FCF ratio of 4.19 is amongst the best of the industry. ATRC outperforms 80.32% of its industry peers.
ATRC has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
ATRC has a Debt to Equity ratio of 0.14. This is in the better half of the industry: ATRC outperforms 62.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | 4.19 | ||
| Altman-Z | 6.77 |
ROIC/WACCN/A
WACC8.58%
2.3 Liquidity
A Current Ratio of 3.87 indicates that ATRC has no problem at all paying its short term obligations.
The Current ratio of ATRC (3.87) is better than 68.62% of its industry peers.
ATRC has a Quick Ratio of 2.85. This indicates that ATRC is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.85, ATRC is doing good in the industry, outperforming 64.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.87 | ||
| Quick Ratio | 2.85 |
3. Growth
3.1 Past
ATRC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 69.88%, which is quite impressive.
The Revenue has grown by 15.80% in the past year. This is quite good.
Measured over the past years, ATRC shows a quite strong growth in Revenue. The Revenue has been growing by 15.05% on average per year.
EPS 1Y (TTM)69.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.12%
Revenue 1Y (TTM)15.8%
Revenue growth 3Y19.26%
Revenue growth 5Y15.05%
Sales Q2Q%15.84%
3.2 Future
The Earnings Per Share is expected to grow by 23.01% on average over the next years. This is a very strong growth
ATRC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.24% yearly.
EPS Next Y40.44%
EPS Next 2Y31.48%
EPS Next 3Y31.18%
EPS Next 5Y23.01%
Revenue Next Year15.08%
Revenue Next 2Y13.68%
Revenue Next 3Y13.55%
Revenue Next 5Y13.24%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ATRC. In the last year negative earnings were reported.
Also next year ATRC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, ATRC is valued a bit cheaper than 69.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 107.31 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as ATRC's earnings are expected to grow with 31.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.48%
EPS Next 3Y31.18%
5. Dividend
5.1 Amount
ATRC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
35.09
-1.03 (-2.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners100.55%
Inst Owner Change-2.45%
Ins Owners3.41%
Ins Owner Change-1.04%
Market Cap1.74B
Revenue(TTM)518.30M
Net Income(TTM)-29.20M
Analysts85.33
Price Target52.7 (50.19%)
Short Float %4.8%
Short Ratio4.66
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)89.89%
Min EPS beat(2)88.31%
Max EPS beat(2)91.46%
EPS beat(4)4
Avg EPS beat(4)71.41%
Min EPS beat(4)40.06%
Max EPS beat(4)91.46%
EPS beat(8)7
Avg EPS beat(8)36.37%
EPS beat(12)11
Avg EPS beat(12)39.56%
EPS beat(16)11
Avg EPS beat(16)28.77%
Revenue beat(2)2
Avg Revenue beat(2)1.41%
Min Revenue beat(2)0.29%
Max Revenue beat(2)2.54%
Revenue beat(4)2
Avg Revenue beat(4)0.36%
Min Revenue beat(4)-1.4%
Max Revenue beat(4)2.54%
Revenue beat(8)4
Avg Revenue beat(8)0.17%
Revenue beat(12)6
Avg Revenue beat(12)0.47%
Revenue beat(16)9
Avg Revenue beat(16)0.72%
PT rev (1m)1.31%
PT rev (3m)1.31%
EPS NQ rev (1m)-12.31%
EPS NQ rev (3m)-11.06%
EPS NY rev (1m)15.92%
EPS NY rev (3m)7.37%
Revenue NQ rev (1m)-0.26%
Revenue NQ rev (3m)-0.26%
Revenue NY rev (1m)0.5%
Revenue NY rev (3m)0.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 3.37 | ||
| P/FCF | 107.31 | ||
| P/OCF | 40.63 | ||
| P/B | 3.66 | ||
| P/tB | 9.11 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.25
EYN/A
EPS(NY)-0.19
Fwd EYN/A
FCF(TTM)0.33
FCFY0.93%
OCF(TTM)0.86
OCFY2.46%
SpS10.42
BVpS9.58
TBVpS3.85
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.6% | ||
| ROE | -6.13% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 74.87% | ||
| FCFM | 3.14% |
ROA(3y)-6.75%
ROA(5y)-3.76%
ROE(3y)-8.8%
ROE(5y)-5.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y0.24%
F-Score7
Asset Turnover0.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | 4.19 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 133.13% | ||
| Cap/Sales | 5.15% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.87 | ||
| Quick Ratio | 2.85 | ||
| Altman-Z | 6.77 |
F-Score7
WACC8.58%
ROIC/WACCN/A
Cap/Depr(3y)184.3%
Cap/Depr(5y)140.27%
Cap/Sales(3y)6.89%
Cap/Sales(5y)5.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.12%
EPS Next Y40.44%
EPS Next 2Y31.48%
EPS Next 3Y31.18%
EPS Next 5Y23.01%
Revenue 1Y (TTM)15.8%
Revenue growth 3Y19.26%
Revenue growth 5Y15.05%
Sales Q2Q%15.84%
Revenue Next Year15.08%
Revenue Next 2Y13.68%
Revenue Next 3Y13.55%
Revenue Next 5Y13.24%
EBIT growth 1Y21.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year242.67%
EBIT Next 3Y62.94%
EBIT Next 5Y43.19%
FCF growth 1Y137.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8487.4%
OCF growth 3YN/A
OCF growth 5YN/A
ATRICURE INC / ATRC FAQ
What is the fundamental rating for ATRC stock?
ChartMill assigns a fundamental rating of 4 / 10 to ATRC.
What is the valuation status of ATRICURE INC (ATRC) stock?
ChartMill assigns a valuation rating of 2 / 10 to ATRICURE INC (ATRC). This can be considered as Overvalued.
What is the profitability of ATRC stock?
ATRICURE INC (ATRC) has a profitability rating of 3 / 10.
What is the earnings growth outlook for ATRICURE INC?
The Earnings per Share (EPS) of ATRICURE INC (ATRC) is expected to grow by 40.44% in the next year.